KRAS and pancreatic intraductal papillary-mucinous neoplasm: Unlike Gnas mutations, the knockout or mutation of Rnf43 only accelerates Kras-driven tumorigenesis [42] and has not been verified to simulate IPMN lesions in mouse models.